Mid-Term Results of a Cemented Titanium–Niobium Nitride-Coated Mobile Knee in Primary Total Knee Arthroplasty
Year: 2025
Type: article
Study design: Observational Study
Abstract: Objectives: Materials with ceramic surface treatments have been adopted in total knee arthroplasty (TKA) to limit polyethylene wear and thus extend implant longevity. This study evaluated, at a single center, mid-term survivorship and clinical outcomes for a mobile-bearing knee prosthesis with a titanium–niobium nitride (TiNbN) coating. Methods: A total of 150 patients who underwent primary cemented TKA using the same TiNbN-coated mobile-bearing prosthesis were identified through the institutional database. Of these, 102 patients (102 knees) attended the follow-up examination and provided informed consent to participate in this study. All patients underwent comprehensive clinical and radiological assessment. Primary outcomes were the Forgotten Joint Score (FJS) and the Knee Injury and Osteoarthritis Outcome Score (KOOS). Results: After a mean follow-up period of 7.9 years, two revision surgeries were recorded. One revision was performed due to late periprosthetic joint infection, while the other involved synovectomy and liner exchange due to persistent stiffness and pain. At 9 years follow-up, overall survivorship of the TiNbN-coated TKA was 97.1% (95% CI, 88.4–99.3%). Mean FJS and KOOS were 70.0 (range 29–100) and 70.6 (range 24–98), respectively. No sex-based differences were detected in clinical outcomes or implant survivorship. Conclusions: The TiNbN-coated mobile-bearing knee prosthesis demonstrated favorable mid-term survivorship and patient-reported outcomes. These findings support its use as a treatment option for knee osteoarthritis, with performance comparable to contemporary TKA designs.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm14186357
Authors: Serdar Jure, Mislav Čimić, Domagoj Delimar
Institutions: University Hospital Centre Zagreb, University of Zagreb
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W4414099314
